KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 92 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,180 | +156.0% | 58,378 | +79.7% | 0.00% | -75.0% |
| Q4 2022 | $219,578 | -89.8% | 32,482 | -78.2% | 0.00% | -90.2% |
| Q3 2022 | $2,160,000 | +7.4% | 148,867 | -27.1% | 0.04% | -25.5% |
| Q2 2022 | $2,011,000 | +112.6% | 204,338 | +218.2% | 0.06% | +120.0% |
| Q1 2022 | $946,000 | +368.3% | 64,210 | +285.0% | 0.02% | -44.4% |
| Q2 2020 | $202,000 | +27.0% | 16,676 | -19.8% | 0.04% | +28.6% |
| Q1 2020 | $159,000 | – | 20,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |